Hematology and Medical Oncology Fellowship at Hackensack University Medical Center
Welcome Message from the Program Director
Thank you for your interest in the Hematology and Medical Oncology Fellowship Program at Hackensack University Medical Center.
Our mission is to equip the next generation of physicians with the knowledge and skills needed to provide compassionate and comprehensive care for patients with hematologic and neoplastic disorders. We recognize that hematology/oncology is in a period of dramatic evolution and, as such, the tools required are similarly evolving. We also believe there are many ways to be a leader in our field today, and tomorrow. It is our privilege to train our future leaders and facilitate the realization of their unique aspirations.
At our fellowship program’s core are four interconnected principles: Exceptional Clinical Care, Social Awareness, Communication, and Scholarship. We offer fellows the opportunity to hone their craft and embody these principles through clinical, educational, and scholarly experiences at a leading cancer center, serving a large and diverse patient population, amid a supportive, multidisciplinary culture.
Christina Cho, M.D.
Program Director, Hematology/Oncology
Director, Adult Gene Therapy Program
Assistant Professor of Medicine
Andrew Ip, M.D.
Associate Program Director, Hematology/Oncology
Director, Outcomes and Value Care Division
Assistant Professor of Medicine
Contact Us
Michelle Carreras
Program Coordinator
Email: michelle.carreras@hmhn.org
Phone: 551-996-4469
John Theurer Cancer Center at Hackensack University Medical Center
The flagship anchor of cancer care at Hackensack Meridian Health, John Theurer Cancer Center at Hackensack University Medical Center is recognized as the best cancer center in New Jersey and ranked amongst the top 50 Cancer Centers Nationwide by U.S. News & World Report. We are also the largest and most comprehensive center dedicated to diagnosis, treatment, management, research, screening, and preventive care as well as survivorship of patients with all types of cancers. The 16 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. JTCC is part of the National Cancer Institute–designated Georgetown Lombardi Comprehensive Cancer Center. Our institutions, which began their collaboration in 2015, share passion and expertise in research, which help to develop new therapies and understand cancer at the population level. Fellows will participate in the care of patients receiving treatment on numerous clinical trials, including phase I therapeutics and novel cell-based therapies, and have the opportunity to collaborate with investigators across the consortium, including translational and laboratory-based scientists at Hackensack Meridian Health’s Center for Discovery and Innovation.
Hackensack University Medical Center the #1 adult hospital in New Jersey making it the #1 adult and children’s Hospital in the State and among TOP 50 Cancer Centers in the Nation by Us News and World Reports.